19th IDS Congress
Paris 2023

23-27 May. 2023

The Immunology of Diabetes Society (IDS) is a scientific society dedicated to improving understanding and treatment of type 1 diabetes. IDS organizes a Congress every 18 months in major centres in Europe, North America and Asia/Oceania at which there are scientific presentations to further this goal.

Centre international de Conférences Sorbonne Université

4 place Jussieu - 44-55

75005 - Paris, France

logo ids_edited.jpg
*To submit before 15th February 2023
logosorbonne.png

Confirmed Speakers

(by alphabetical order)

Peter Achenbach, Mark Atkinson, Jean-François Bach, Burkhard Becher, Polly Bingley, Christian Boitard, Ezio Enrico Bonifacio, Marcela Brissova, Todd Brusko, Jenny Couper, Mark M. Davis, Gerard Eberl, Decio L. Eizirik, Donna Farber, Jean-François Gautier, Carla Greenbaum, John Harris, Len Harrisson, Matthias Hebrok, Kevan Herold, Heikki Hyoty, Sally Kent, David Klatzmann, Aaron J. Kowalski, Jeffrey Krischer, Vito Lampasona, Peter E. Lipsky, Chantal Mathieu, Eoin McKinney, Gerald T. Nepom, Maria Cristina Nostro, Timo Otonkoski, Alberto Pugliese, Frédéric Rieux-Laucat, Bart Roep, Miguel Sanjuan, Pere Santamaria, Andrea Schietinger, Anath Shalev, Tommi Suvitaival, Qizhi Tang, Timothy Tree, Tommi Vatanen, Carola Vinuesa, John Wentworth, Benjamin Youngblood, Anette Ziegler

 Wednesday 24th

8.20 am

11.00 am

Plenary 2: Eisenbarth Award Lecture – presented by M. Rewers

Len Harrison (Walter & Eliza Hall Institute, Melbourne)
 

9.00 am

Short Symposium 2: Immune and pancreas heterogeneity
 

Short Symposium 2: Immune and pancreas heterogeneity
 

Talk 7: Immune heterogeneity – HANDEL-I: Todd Brusko (University of Florida, Gainesville)
 

Talk 8: Pancreas heterogeneity – HANDEL-P: Marcela Brissova (Vanderbilt University, Nashville)
 

Oral Abstract 4

Oral Abstract 5

Oral Abstract 6

Long Symposium 2: Innovative interventions and preclinical development

Talk 9:  Verapamil: Anath Shalev (University of Alabama, Birmingham)

Talk 10: HLA Class II nanoparticles: P. Santamaria (Parvus Therapeutics)

Talk 11:  CAR Treg therapies: Qizhi Tang (UCSF)

Oral Abstract 7

Oral Abstract 8

Oral Abstract 9

1.00 pm

10.30 - 11 am
Break

1.00 - 2.00 pm
Lunch

2.00 pm

4.30 pm 

Long Symposium 3: iPS-derived beta cells, present and future

Talk 12: Disease modeling using iPS islets: Timo Otonkoski (University of Helsinki)

Talk 13: Regeneration vs carcinogenesis: Maria Cristina Nostro (McEwen Stem Cell Institute, Toronto)

Talk 14: Creating stealthy beta cells: Matthias Hebrok (UCSF, San Francisco)

Oral Abstract 10

Oral Abstract 11

Oral Abstract 12

Debate 1: Infectious triggers in T1D: myth or reality?
 

Myth: Bart Roep (LUMC, Leiden)

Reality: Heikki Hyoty (University of Tampere)

5.30 pm 

Poster Blast 2  (16 to 30) 

90” and 1 plain slide/each

6.00 pm 

4.00 - 4.30 pm
Break

Poster Session 2  (16 to 30) 
 

7.30 pm

Dinner on your own